Senseonics to Showcase Innovative Diabetes Tech at Conference
Senseonics Holdings, Inc. to Participate in Upcoming Conference
GERMANTOWN, Md. — Senseonics Holdings, Inc. (NYSE American: SENS), a leading medical technology company specializing in long-term implantable continuous glucose monitoring (CGM) systems for diabetes management, has announced its upcoming participation in a prestigious investment event. The H.C. Wainwright 26th Annual Global Investment Conference will take place in New York, highlighting innovative advancements in the field.
Management Presentation Schedule
The management team of Senseonics is set to present on Tuesday at 11:30 AM ET, during which they will also engage in one-on-one meetings. This is a prime opportunity for investors and stakeholders to learn more about the company's vision and the revolutionary technology that is transforming diabetes care.
Innovative Technology at the Forefront
Senseonics is at the cutting edge of medical technology with its distinct glucose monitoring solutions. Their flagship product, the Eversense® E3 CGM system, boasts a small sensor that is implanted under the skin and connects with a smart transmitter worn outside. This innovative technology allows users to receive real-time glucose data every five minutes via a mobile application on their smartphones, significantly streamlining diabetes management.
The Future of Diabetes Management
The aim of Senseonics is to enhance the quality of life for individuals in the global diabetes community. The long-term implantable glucose management technology is designed not only to monitor glucose levels but also to provide users with convenient accessibility to their health data. This ensures that they have better control over their health and can make informed decisions regarding their diabetes management.
Engaging with Stakeholders
For those interested in the developments at Senseonics, a live and recorded webcast of the presentation will be accessible through the company’s Investor Relations section on its website. This webcast provides a valuable resource for investors who wish to understand the company’s strategies and advancements in the diabetes tech landscape.
Contacting Senseonics
If you have questions or require additional information, the investor relations contact for Senseonics is Jeremy Feffer from LifeSci Advisors. He is available to address inquiries regarding the company, its products, and investment opportunities. Interested parties can reach out via the provided email for further engagement.
Frequently Asked Questions
What is the main focus of Senseonics Holdings, Inc.?
Senseonics specializes in the development of long-term, implantable continuous glucose monitoring systems designed for people with diabetes.
What is the Eversense® E3 system?
The Eversense® E3 system is an innovative glucose monitoring device that includes an implantable sensor under the skin, which connects to a smart transmitter for real-time data.
When and where will the H.C. Wainwright 26th Annual Global Investment Conference take place?
The conference will be held on Tuesday, featuring various presentations and one-on-one meetings in New York City.
How can I access the company’s webcast presentation?
Interested individuals can access the live and recorded webcast of Senseonics' presentation through the Investor Relations section of their official website.
Who can I contact for more information about Senseonics?
For further information, investors can contact Jeremy Feffer at LifeSci Advisors via the provided email address for any investor-related queries.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.